Lukas M Carter1, Troy M Crawford2, Tatsuhiko Sato3,4, Takuya Furuta3, Chansoo Choi5, Chan Hyeong Kim5, Justin L Brown6, Wesley E Bolch6, Pat B Zanzonico7, Jason S Lewis8,9. 1. Program in Pharmacology, the Radiochemistry and Molecular Imaging Probes Core, and the Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York. 2. Department of Physics, University of Rhode Island, Kingston, Rhode Island. 3. Japan Atomic Energy Agency, Ibaraki, Japan. 4. Research Center for Nuclear Physics, Osaka University, Osaka, Japan. 5. Department of Nuclear Engineering, Hanyang University, Seoul, Korea. 6. J. Crayton Pruitt Family Department of Biomedical Engineering, University of Florida, Gainesville, Florida. 7. Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York; and. 8. Program in Pharmacology, the Radiochemistry and Molecular Imaging Probes Core, and the Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York lewisj2@mskcc.org. 9. Department of Radiology and Department of Pharmacology, Weill Cornell Medical College, New York, New York.
Abstract
Mesh-type and voxel-based computational phantoms comprise the current state of the art for internal dose assessment via Monte Carlo simulations but excel in different aspects, with mesh-type phantoms offering advantages over their voxel counterparts in terms of their flexibility and realistic representation of detailed patient- or subject-specific anatomy. We have developed PARaDIM (pronounced "paradigm": Particle and Heavy Ion Transport Code System-Based Application for Radionuclide Dosimetry in Meshes), a freeware application for implementing tetrahedral mesh-type phantoms in absorbed dose calculations. It considers all medically relevant radionuclides, including α, β, γ, positron, and Auger/conversion electron emitters, and handles calculation of mean dose to individual regions, as well as 3-dimensional dose distributions for visualization and analysis in a variety of medical imaging software. This work describes the development of PARaDIM, documents the measures taken to test and validate its performance, and presents examples of its uses. Methods: Human, small-animal, and cell-level dose calculations were performed with PARaDIM and the results compared with those of widely accepted dosimetry programs and literature data. Several tetrahedral phantoms were developed or adapted using computer-aided modeling techniques for these comparisons. Results: For human dose calculations, agreement of PARaDIM with OLINDA 2.0 was good-within 10%-20% for most organs-despite geometric differences among the phantoms tested. Agreement with MIRDcell for cell-level S value calculations was within 5% in most cases. Conclusion: PARaDIM extends the use of Monte Carlo dose calculations to the broader community in nuclear medicine by providing a user-friendly graphical user interface for calculation setup and execution. PARaDIM leverages the enhanced anatomic realism provided by advanced computational reference phantoms or bespoke image-derived phantoms to enable improved assessments of radiation doses in a variety of radiopharmaceutical use cases, research, and preclinical development. PARaDIM can be downloaded freely at www.paradim-dose.org.
Mesh-type and voxel-based computational phantoms comprise the current state of the art for internal dose assessment via Monte Carlo simulations but excel in different aspects, with mesh-type phantoms offering advantages over their voxel counterparts in terms of their flexibility and realistic representation of detailed patient- or subject-specific anatomy. We have developed PARaDIM (pronounced "paradigm": Particle and Heavy Ion Transport Code System-Based Application for Radionuclide Dosimetry in Meshes), a freeware application for implementing tetrahedral mesh-type phantoms in absorbed dose calculations. It considers all medically relevant radionuclides, including α, β, γ, positron, and Auger/conversion electron emitters, and handles calculation of mean dose to individual regions, as well as 3-dimensional dose distributions for visualization and analysis in a variety of medical imaging software. This work describes the development of PARaDIM, documents the measures taken to test and validate its performance, and presents examples of its uses. Methods:Human, small-animal, and cell-level dose calculations were performed with PARaDIM and the results compared with those of widely accepted dosimetry programs and literature data. Several tetrahedral phantoms were developed or adapted using computer-aided modeling techniques for these comparisons. Results: For human dose calculations, agreement of PARaDIM with OLINDA 2.0 was good-within 10%-20% for most organs-despite geometric differences among the phantoms tested. Agreement with MIRDcell for cell-level S value calculations was within 5% in most cases. Conclusion: PARaDIM extends the use of Monte Carlo dose calculations to the broader community in nuclear medicine by providing a user-friendly graphical user interface for calculation setup and execution. PARaDIM leverages the enhanced anatomic realism provided by advanced computational reference phantoms or bespoke image-derived phantoms to enable improved assessments of radiation doses in a variety of radiopharmaceutical use cases, research, and preclinical development. PARaDIM can be downloaded freely at www.paradim-dose.org.
Authors: C H Kim; Y S Yeom; T T Nguyen; Z J Wang; H S Kim; M C Han; J K Lee; M Zankl; N Petoussi-Henss; W E Bolch; C Lee; B S Chung Journal: Ann ICRP Date: 2016-03-11
Authors: Kenneth Clark; Bruce Vendt; Kirk Smith; John Freymann; Justin Kirby; Paul Koppel; Stephen Moore; Stanley Phillips; David Maffitt; Michael Pringle; Lawrence Tarbox; Fred Prior Journal: J Digit Imaging Date: 2013-12 Impact factor: 4.056
Authors: Joshua A Korsen; Julia A Gutierrez; Kathryn M Tully; Lukas M Carter; Zachary V Samuels; Samantha Khitrov; John T Poirier; Charles M Rudin; Yu Chen; Michael J Morris; Lisa Bodei; Nagavarakishore Pillarsetty; Jason S Lewis Journal: Proc Natl Acad Sci U S A Date: 2022-06-27 Impact factor: 12.779
Authors: David Bauer; Hannah Visca; Anuradha Weerakkody; Lukas M Carter; Zachary Samuels; Spencer Kaminsky; Oleg A Andreev; Yana K Reshetnyak; Jason S Lewis Journal: Front Oncol Date: 2022-05-19 Impact factor: 5.738
Authors: Giacomo Pirovano; Stephen A Jannetti; Lukas M Carter; Ahmad Sadique; Susanne Kossatz; Navjot Guru; Paula Demétrio De Souza França; Masatomo Maeda; Brian M Zeglis; Jason S Lewis; John L Humm; Thomas Reiner Journal: Clin Cancer Res Date: 2020-02-17 Impact factor: 12.531
Authors: Jason S Lewis; Adam L Kesner; Lukas M Carter; Juan Camilo Ocampo Ramos; Wesley E Bolch Journal: Med Phys Date: 2021-03-09 Impact factor: 4.071
Authors: Megan M Dacek; Darren R Veach; Sarah M Cheal; Lukas M Carter; Michael R McDevitt; Blesida Punzalan; Daniela Burnes Vargas; Thomas Z Kubik; Sebastien Monette; Brian H Santich; Guangbin Yang; Ouathek Ouerfelli; Adam L Kesner; Nai-Kong V Cheung; David A Scheinberg; Steven M Larson; Simone Krebs Journal: Bioconjug Chem Date: 2021-04-05 Impact factor: 4.774